Allianz Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.82M | Buy |
112,500
+15,600
| +16% | +$909K | 0.01% | 1029 |
|
|
2025
Q4 | $5.23M | Buy |
96,900
+22,100
| +30% | +$1.06M | 0.01% | 1123 |
|
|
2025
Q3 | $3.37M | Sell |
74,800
-59,500
| -44% | -$2.78M | ﹤0.01% | 1286 |
|
|
2025
Q2 | $6.22M | Buy |
134,300
+63,900
| +91% | +$3.14M | 0.01% | 998 |
|
|
2025
Q1 | $4.29M | Buy |
70,400
+7,900
| +13% | +$460K | 0.01% | 1191 |
|
|
2024
Q4 | $3.54M | Sell |
62,500
-35,700
| -36% | -$1.99M | ﹤0.01% | 1193 |
|
|
2024
Q3 | $5.08M | Buy |
98,200
+45,400
| +86% | +$2.13M | 0.01% | 1043 |
|
|
2024
Q2 | $2.19M | Buy |
52,800
+49,300
| +1,409% | +$2.21M | ﹤0.01% | 1280 |
|
|
2024
Q1 | $190K | Sell |
3,500
-126,000
| -97% | -$6.42M | ﹤0.01% | 1853 |
|
|
2023
Q4 | $6.64M | Sell |
129,500
-108,400
| -46% | -$5.69M | 0.01% | 821 |
|
|
2023
Q3 | $13.8M | Buy |
237,900
+109,700
| +86% | +$6.72M | 0.02% | 602 |
|
|
2023
Q2 | $8.2M | Sell |
128,200
-15,300
| -11% | -$1.03M | 0.01% | 710 |
|
|
2023
Q1 | $9.95M | Buy |
143,500
+20,600
| +17% | +$1.45M | 0.02% | 699 |
|
|
2022
Q4 | $8.84M | Buy |
122,900
+12,000
| +11% | +$905K | 0.02% | 719 |
|
|
2022
Q3 | $7.88M | Buy |
110,900
+84,100
| +314% | +$6.1M | 0.02% | 736 |
|
|
2022
Q2 | $2.06M | Sell |
26,800
-100,800
| -79% | -$7.68M | ﹤0.01% | 1414 |
|
|
2022
Q1 | $9.32M | Buy |
127,600
+52,900
| +71% | +$3.55M | 0.01% | 1013 |
|
|
2021
Q4 | $4.66M | Sell |
74,700
-46,400
| -38% | -$2.72M | ﹤0.01% | 1265 |
|
|
2021
Q3 | $7.17M | Buy |
121,100
+88,600
| +273% | +$5.83M | 0.01% | 1137 |
|
|
2021
Q2 | $2.17M | Sell |
32,500
-22,600
| -41% | -$1.47M | ﹤0.01% | 1446 |
|
|
2021
Q1 | $3.48M | Buy |
+55,100
| New | +$3.43M | ﹤0.01% | 1201 |
|
|
2020
Q3 | – | Sell |
-297,200
| Closed | -$17.5M | – | 1921 |
|
|
2020
Q2 | $17.5M | Buy |
297,200
+116,500
| +64% | +$6.97M | 0.02% | 682 |
|
|
2020
Q1 | $10.1M | Sell |
180,700
-254,900
| -59% | -$15.6M | 0.01% | 844 |
|
|
2019
Q4 | $28M | Buy |
435,600
+88,200
| +25% | +$5.05M | 0.03% | 647 |
|
|
2019
Q3 | $17.6M | Sell |
347,400
-38,900
| -10% | -$1.83M | 0.02% | 829 |
|
|
2019
Q2 | $17.5M | Sell |
386,300
-114,800
| -23% | -$5.35M | 0.02% | 866 |
|
|
2019
Q1 | $23.9M | Sell |
501,100
-73,700
| -13% | -$3.67M | 0.02% | 686 |
|
|
2018
Q4 | $29.9M | Sell |
574,800
-181,500
| -24% | -$9.75M | 0.03% | 528 |
|
|
2018
Q3 | $47M | Sell |
756,300
-150,700
| -17% | -$8.94M | 0.04% | 457 |
|
|
2018
Q2 | $50.2M | Sell |
907,000
-17,800
| -2% | -$961K | 0.05% | 404 |
|
|
2018
Q1 | $58.5M | Sell |
924,800
-1,561,900
| -63% | -$100M | 0.06% | 365 |
|
|
2017
Q4 | $152M | Buy |
2,486,700
+259,500
| +12% | +$16.2M | 0.12% | 186 |
|
|
2017
Q3 | $142M | Buy |
2,227,200
+570,400
| +34% | +$33.3M | 0.12% | 188 |
|
|
2017
Q2 | $92.3M | Sell |
1,656,800
-32,500
| -2% | -$1.77M | 0.09% | 264 |
|
|
2017
Q1 | $91.9M | Sell |
1,689,300
-1,274,900
| -43% | -$69.9M | 0.09% | 261 |
|
|
2016
Q4 | $173M | Buy |
2,964,200
+1,104,000
| +59% | +$60.4M | 0.15% | 142 |
|
|
2016
Q3 | $100M | Buy |
1,860,200
+446,100
| +32% | +$28.7M | 0.1% | 225 |
|
|
2016
Q2 | $104M | Buy |
1,414,100
+664,700
| +89% | +$47M | 0.11% | 201 |
|
|
2016
Q1 | $47.9M | Buy |
749,400
+54,100
| +8% | +$3.41M | 0.05% | 386 |
|
|
2015
Q4 | $47.8M | Buy |
695,300
+213,500
| +44% | +$14.1M | 0.05% | 407 |
|
|
2015
Q3 | $28.5M | Sell |
481,800
-273,400
| -36% | -$17.3M | 0.03% | 581 |
|
|
2015
Q2 | $50.3M | Buy |
755,200
+233,700
| +45% | +$15.4M | 0.05% | 429 |
|
|
2015
Q1 | $33.6M | Sell |
521,500
-16,800
| -3% | -$1.05M | 0.04% | 512 |
|
|
2014
Q4 | $31.8M | Buy |
538,300
+285,800
| +113% | +$16.1M | 0.04% | 542 |
|
|
2014
Q3 | $12.9M | Buy |
+252,500
| New | +$12.6M | 0.02% | 755 |
|
Other funds holding BMY
VCM
VPM
Allianz Asset Management's BMY Position: Q1 2026 in Review
Allianz Asset Management increased its Bristol-Myers Squibb (BMY) stake by 25% in Q1 2026, buying an estimated $80.7M and bringing the position to 6,879,864 shares worth $417M. The position accounts for 0.44% of the portfolio, ranked #37.
Allianz Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $477M in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Allianz Asset Management held 6,879,864 shares of Bristol-Myers Squibb worth $417M as of Q1 2026.
- Allianz Asset Management bought 1,384,478 Bristol-Myers Squibb shares in Q1 2026, an estimated $80.7M.
- Bristol-Myers Squibb made up 0.44% of Allianz Asset Management's portfolio in Q1 2026, its #37 holding.
- Allianz Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Bristol-Myers Squibb position peaked at $477M in Q4 2019.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.